ArticleFrontiers in nutrition2025
Comparing 11 nutrition-inflammation indices for perioperative management and prognostic evaluation in non-small cell lung cancer patients.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pre-RAI Monocyte-to-Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate-Risk DTC, While PNI and NRI Show No Prognostic Value.Clinical endocrinology · 2026Article
- Molecular Mechanisms Driving Precision Medicine in Perioperative Care: Integrating Inflammation, Metabolism, and Neuroimmunomodulation for Personalized Outcomes.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the establishment of multiple nutrition-inflammation indices, their performances in guiding clinical decision-making have not been systematically compared in patients with non-small cell lung cancer (NSCLC). This study aimed to identify the best nutrition-inflammation index for facilitating perioperative management and prognosis analysis in NSCLC patients. Methods: This study included NSCLC patients who underwent video-assisted thoracoscopic lobectomy as their primary treatment. Nutrition-inflammation indices were calculated based on blood tests and anthropometric measurements conducted within one week prior to surgery. A total of 11 nutrition-inflammation indices were compared for their performance in predicting perioperative and survival outcomes. Results: The cohort consisted of 805 patients, with a mean age of 60.3 years, including 388 females (48.2%) and 417 males (51.8%). Postoperative complications occurred in 152 patients (18.9%). The median follow-up time after surgery was 64.5 months. Most nutrition-inflammation indices demonstrated predictive values for perioperative complications, delayed hospital discharge, and survival outcomes, but with relatively low predictive accuracy. After adjusting for clinicopathological characteristics, most indices were no longer associated with these therapeutic outcomes. Among these indexes, the lymphocyte-to-monocyte ratio showed the best performance in predicting perioperative complications and delayed hospital discharge, while the geriatric nutritional risk index showed the best performance in predicting overall survival and disease-free survival. Conclusion: The current nutrition-inflammation indices demonstrated predictive values for therapeutic outcomes in NSCLC patients, but their utility in clinical practice may be limited due to generally weak independent associations. Future studies should focus on exploring more comprehensive nutrition-inflammation biomarkers for assisting clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.